Venetoclax has been approved!!!
Horray, just came out of a patients room and told her this would be approved by the next time I saw her. I guess I was wrong, it was already approved!
This is a fantastic drug and one of the most effective agents ever in CLL. See the press release (click here). Several years ago, I wrote about BCL-2 as a target (click here)
I have written about tumor lysis previously (click here) and it is worth a read.
This drug is currently approved for patients with relapsed CLL that has 17P deletion - but like ibrutinib will become more and more available as new clinical trials read out.
More later if I can find time to post
Find the time! Thoughts on Combinations, which drug first etc.?
ReplyDeleteHey Doc, would love to see a post comparing Venetoclax to Imbruvica for us if you can. Details of the differences and response rate comparisons would really be awesome for us non medical folks.
ReplyDeleteGreat news!!! I really hope you can find time to post more about it
ReplyDelete